Drug Profile
Solutein
Latest Information Update: 29 Oct 1999
Price :
$50
*
At a glance
- Originator IVAX Pharmaceuticals
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 29 Oct 1999 No-Development-Reported for HIV infections treatment in USA (Injection)
- 20 Feb 1997 New profile
- 20 Feb 1997 Investigation in HIV infections treatment in USA (Injection)